ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Khartis Therapeutics raised $50 million in Series B funding. The financing will support the company's development programs. The round marks a significant capital infusion for the biotech firm.
Tap to vote and see what everyone thinks.
Summary by ByteBrief